Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,391 Jan 1 – Oct 24, 2026
- Disclosed funding
- $205.9B 2015 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| V Builds technologies for spatial biology and multi-omics innovation | $48M | Series A | AI, Biotech | United States | Investors | |
| F Medical imaging data management and analysis platform | $27.5M | Undisclosed | AI, Healthtech | United States | Investors | |
| ET Enodia TherapeuticsCompany profile Develops small-molecule therapies for targeted protein degradation at the point of synthesis Develops small-molecule therapies for targeted protein degradation at the point of synthesis | €20.7M | Seed | AI, Biotech | France | Investors | |
| B BrightHeartCompany profile BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. | €11M | Series A | AI | France | Investors | |
| A Develops specialized AI systems for regulated industries | $70M | Series B | AI | United States | Investors | |
| C CertHubCompany profile Uses AI-driven automation to accelerate medical device approvals and compliance Uses AI-driven automation to accelerate medical device approvals and compliance | €6.2M | Undisclosed | AI, Healthtech | Germany | Investors | |
| PS Provides AI-native due diligence for life sciences dealmaking | $20M | Series A | AI, Biotech | United States | Investors | |
| H Provides AI-powered underwriting technology for mortgage lenders | Undisclosed | StrategicUndisclosed | AI, Fintech | United States | Investors | |
| I Develops AI-based digital biomarkers to support clinical diagnosis. | Undisclosed | StrategicUndisclosed | AI, Healthtech | United States | Investors | |
| ST Uses cells as sensors to uncover first-in-class medicines | $200M | Series CSeries C+ | AI, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Greptile, Nous Research, Halluminate
106rounds2led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
79rounds14led - 3General Catalyst
Legora, Different, Baba
78rounds6led - 4Lightspeed
Warp Sciences, Different, Zenzap
67rounds7led - 5Accel
Legora, Arda Industries
55rounds7led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.